These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 12271422
1. Carbon-11 acetate positron emission tomography can detect local recurrence of prostate cancer. Kotzerke J, Volkmer BG, Neumaier B, Gschwend JE, Hautmann RE, Reske SN. Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1380-4. PubMed ID: 12271422 [Abstract] [Full Text] [Related]
2. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. Oyama N, Miller TR, Dehdashti F, Siegel BA, Fischer KC, Michalski JM, Kibel AS, Andriole GL, Picus J, Welch MJ. J Nucl Med; 2003 Apr; 44(4):549-55. PubMed ID: 12679398 [Abstract] [Full Text] [Related]
3. Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients. Fricke E, Machtens S, Hofmann M, van den Hoff J, Bergh S, Brunkhorst T, Meyer GJ, Karstens JH, Knapp WH, Boerner AR. Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):607-11. PubMed ID: 12589476 [Abstract] [Full Text] [Related]
4. Malignant lipogenesis defined by 11C-acetate PET/CT predicts prostate cancer-specific survival in patients with biochemical relapse after prostatectomy. Regula N, Häggman M, Johansson S, Sörensen J. Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2131-2138. PubMed ID: 27392615 [Abstract] [Full Text] [Related]
9. Value of bimodal (18)F-choline-PET/MRI and trimodal (18)F-choline-PET/MRI/TRUS for the assessment of prostate cancer recurrence after radiation therapy and radical prostatectomy. Paparo F, Piccardo A, Bacigalupo L, Romagnoli A, Piccazzo R, Monticone M, Cevasco L, Campodonico F, Conzi GM, Carmignani G, Rollandi GA. Abdom Imaging; 2015 Aug; 40(6):1772-87. PubMed ID: 25579170 [Abstract] [Full Text] [Related]
14. Carbon-11-acetate positron emission tomography (PET), versus fluorine- 18 fluorodeoxyglucose PET and CT for the diagnosis of recurrent prostate cancer after radical prostatectomy in cases of prostate specific antigen of more than 1 to 3ng/mL. Oyama N, Ito H, Aoki Y, Miwa Y, Akino H, Kudo T, Okazawa H, Fujibayashi Y, Welch M, Yokoyama O. Hell J Nucl Med; 2013 Aug; 16(2):146-7. PubMed ID: 24032176 [No Abstract] [Full Text] [Related]
15. 11C-acetate PET imaging of prostate cancer. Oyama N, Akino H, Kanamaru H, Suzuki Y, Muramoto S, Yonekura Y, Sadato N, Yamamoto K, Okada K. J Nucl Med; 2002 Feb; 43(2):181-6. PubMed ID: 11850482 [Abstract] [Full Text] [Related]